Surgery after Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

被引：0
|
作者：
Bertani, E. [1 ]
Chiappa, A. [1 ]
Fazio, N. [1 ]
Grana, C. [1 ]
Bodei, L. [1 ]
Falconi, M. [2 ]
Ravizza, D. [1 ]
Spada, F. [1 ]
Andreoni, B. [1 ]
机构：
[1] European Inst Oncol, Milan, Italy
[2] Univ Politecn Marche, Pancreas Surg Unit, Ancona, Italy
来源：
NEUROENDOCRINOLOGY | 2014年 / 99卷 / 3-4期
关键词：
neuroendocrine tumors; peptide receptor radionuclide therapy; surgery; survival; progression-free survival;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O2
引用
收藏
页码：285 / 285
页数：1
相关论文
共 50 条
  • [41] Systemic inflammatory index (SII) in neuroendocrine tumors (NETs) treated with peptide receptor radionuclide therapy (PRRT)
    Teran Brage, E.
    Campana-Diaz, E.
    Navarro Martin, M.
    Garcia-Talavera, P.
    Lopez Gutierrez, A.
    Reguera Puertas, P.
    Rama-Alonso, S.
    Roldan Ruiz, J.
    Posado Dominguez, L.
    Pablo Martin, E.
    Lozano Mejorada, R.
    Fonseca Sanchez, E.
    ANNALS OF ONCOLOGY, 2024, 35 : S95 - S95
  • [42] Peptide receptor radionuclide therapy (PRRT) in metastatic neuroendocrine tumors of unknown primary (CUP-NETs)
    Baum, Richard P.
    Wang, Peipei
    Jakobsson, Vivianne
    Zhao, Tianzhi
    Schuchardt, Christiane
    Khong, Pek-Lan
    Zhang, Jingjing
    THERANOSTICS, 2024, 14 (01): : 133 - 142
  • [43] Peptide Receptor Radionuclide Therapy (PRRT) for Metastatic Neuroendocrine Tumors (NETs) in a United States (US) Population
    Katona, Bryson W.
    Riff, Brian P.
    Soulen, Michael C.
    Pryma, Daniel A.
    Bennett, Bonita J.
    Wild, Damian
    Nicolas, Guillaume
    Teitelbaum, Ursina R.
    Metz, David C.
    GASTROENTEROLOGY, 2016, 150 (04) : S208 - S209
  • [44] The Sequencing of Lanreotide (LAN) After Octreotide LAR (OCT) for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
    Saif, Wasif M.
    Parikh, Rohan C.
    Ray, David
    Kaye, James A.
    Kurosky, Samantha K.
    Thomas, Katharine
    Halfdanarson, Thorvardur R.
    Beveridge, Thomas
    Mirakhur, Beloo
    Lubeck, Catherine A.
    Nagar, Saurabh
    Soares, Heloisa
    PANCREAS, 2019, 48 (03) : 450 - 450
  • [45] Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors with somatostatin analogues
    Bodei, L.
    Pepe, G.
    Paganelli, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2010, 14 (04) : 347 - 351
  • [46] Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): Our Experience in a Multidisciplinary Team in a University Hospital
    Cabezas-Agricola, J. M.
    Baron-Duarte, F.
    Fernandez-Rodriguez, E.
    Varo, E.
    Cameselle-Teijeiro, J. M.
    Iglesias, J.
    Argibay, S.
    Villalba, C.
    Fernandez-Castroagudin, J.
    Otero-Anton, E.
    NEUROENDOCRINOLOGY, 2010, 92 (01) : 22 - 23
  • [47] Clonal Hematopoiesis in Patients with Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy (PRRT)
    Singh, Abhay
    Gravina, Matthew
    Tajammal, Rutaba
    Nowak, Annmarie
    Iyer, Renuka
    Faber, Mark G.
    Yan, LunBiao
    Hassane, Duane C.
    Guzman, Monica L.
    Mencia-Trinchant, Nuria
    Wang, Eunice S.
    Thota, Swapna
    BLOOD, 2020, 136
  • [48] US real-world study of the burden of medication in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
    Chan, J. A.
    Houchard, A.
    Pommie, C.
    Ribeiro-Oliveira, A., Jr.
    Starr, J.
    Vandamme, T.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 86 - 86
  • [49] Differential prognosis according to metastatic patterns in advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
    Rosas, V.
    Rosales Sotomayor, A.
    Hernandez Martinez, A.
    Gamboa Dominguez, A.
    Noguez Ramos, A.
    Huitzil Melendez, F. D.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S416 - S417
  • [50] SYSTEMIC TREATMENT OF GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS (GEP-NETS): CURRENT APPROACHES AND FUTURE OPTIONS
    Strosberg, Jonathan R.
    ENDOCRINE PRACTICE, 2014, 20 (02) : 167 - 175
12345